Corrigendum to “Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells” [Bioact. Mater. 45 (2025), 181–200]

Peng Tang; Fuxiang Wei; Weihua Qiao; Xing Chen; Chenyang Ji; Wanzhi Yang; Xinyu Zhang; Sihan Chen; Yanyan Wu; Mingxing Jiang; Chenyu Ma; Weiqiang Shen; Qi Dong; Hong Cao; Minghui Xie; Ziwen Cai; Li Xu; Jiawei Shi; Nianguo Dong; Junwei Chen; Ning Wang

doi:10.1016/j.bioactmat.2025.12.014

Corrigendum to “Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells” [Bioact. Mater. 45 (2025), 181–200]

Bioactive Materials 2026 Open access

Read full text

Authors: Peng Tang, Fuxiang Wei, Weihua Qiao, Xing Chen, Chenyang Ji, Wanzhi Yang, Xinyu Zhang, Sihan Chen, Yanyan Wu, Mingxing Jiang, Chenyu Ma, Weiqiang Shen

+9 more

Qi Dong, Hong Cao, Minghui Xie, Ziwen Cai, Li Xu, Jiawei Shi, Nianguo Dong, Junwei Chen, Ning Wang

DOI: 10.1016/j.bioactmat.2025.12.014

Cited by: 0

Abstract

[This corrects the article DOI: 10.1016/j.bioactmat.2024.11.018.].

Fields of Study & Subjects

Tissue Engineering and Regenerative Medicine Cardiac Valve Diseases and Treatments Mesenchymal stem cell research

Publication details

Journal / source: Bioactive Materials
Volume: 60
Pages: 280–281
Publication date: 28 January 2026
Language: EN